Pharmanutra S.p.A.

PHN

IT0005274094

Pharmaceuticals

Real-time Borsa Italiana Other stock markets 08:03:06 2024-05-20 am EDT			5-day change	1st Jan Change
47.65 ^EUR	-0.73%		-6.02%	-15.51%

May. 16	Pharmanutra S.p.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 15	Indices expected to rise ahead of macro data	AN

The importance of iron in pregnancy: benefits for mothers and babies

May 02, 2024 at 09:03 am EDT

02 May 2024 | NewsScience Pregnant women in many regions of the world are at risk of developing iron deficiency anemia. Preventive strategies, such as iron integration and food education, are crucial to address this sensitive issue. [...]

This is an abstract of the document. To keep reading, click here and get access to the original version.

Attachments

Original Link
Permalink

Disclaimer

Pharmanutra S.p.A. published this content on 02 May 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 May 2024 12:58:26 UTC.

Latest news about Pharmanutra S.p.A.

Pharmanutra S.p.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 15	CI
Indices expected to rise ahead of macro data	May. 15	AN
Mib on highs since 2008 dragged by banks	May. 14	AN
PharmaNutra, profit down sharply in quarter; revenues improve	May. 13	AN
Lists in green except Mib; banks good	Apr. 22	AN
Iveco down on Mib; European stock exchanges in green	Apr. 22	AN
Futures await bourses up; China holds rates	Apr. 22	AN
Mib closes bullish; Terna takes top spot	Apr. 19	AN
PharmaNutra Gets Approvals to Merge Subsidiaries	Apr. 15	MT
PharmaNutra approves merger of Junia Pharma and Alesco	Apr. 15	AN
Futures passive; BoJ abandons negative rates.	Mar. 19	AN
Milan at parity; De Nora on bottom after accounts	Mar. 18	AN
PharmaNutra increases revenues to double digits in 2023	Mar. 15	AN
Pharmanutra S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 14	CI
Mib at peak since 2008; MPS updates annual max	Mar. 01	AN
Mib rallying; Saipem still bullish after accounts	Mar. 01	AN
Mib bearish; spotlight on US PCE data	Feb. 28	AN
Global markets live: Chevron, Expedia, Standard Chartered, Broadcom, Meta Platforms...	Feb. 27
Mib bullish above 32,700; Saipem on top	Feb. 27	AN
Europeans above parity; accounts push Campari	Feb. 27	AN
Indices up against expectations; Moncler recovers	Feb. 27	AN
PharmaNutra Approves Absorption of Two Units to Improve Group's Management Efficiency	Feb. 27	MT
PharmaNutra incorporates subsidiaries Junia Pharma and Alesco	Feb. 26	AN
Indices down; Italian inflation at 5.7 percent in 2023	Jan. 16	AN
Stock markets in the red in Europe; Mib above 30,100 threshold	Jan. 16	AN

Chart Pharmanutra S.p.A.

Duration

Period

More charts

Company Profile

Pharmanutra SpA is an Italy-based company engaged in the healthcare industry. The Company develops nutraceutical products and medical devices. It focuses on studying and producing formulations that are backed up in scientific research. It is able to cover all stages of the development of a product, from its design, formulation and registration to its marketing, distribution and training of its commercial representatives. The Company offers Gestalys DHA, a nutritional supplement; Cetilar, a massage coadiuvant, improves and brings relief to joints affected by osteoarthritis; Cetilar patch, a transdermic patch containing a concentrated formulation of cetylated fatty acids (CFA) esters; SiderAL Forte; CardioSiderAL; SiderAL Folico; SiderAL; Bonecal and Novomega, among others.

Sector

Pharmaceuticals

Calendar

2024-09-08 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Pharmanutra S.p.A.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

48 EUR

Average target price

80.33 EUR

Spread / Average Target

+67.36%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
PHARMANUTRA S.P.A.	-15.51%	502M
ELI LILLY AND COMPANY	+32.09%	693B
NOVO NORDISK A/S	+29.39%	584B
JOHNSON & JOHNSON	-1.34%	372B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+7.39%	294B
ASTRAZENECA PLC	+13.87%	239B
ROCHE HOLDING AG	-3.03%	211B
NOVARTIS AG	+10.02%	210B
AMGEN INC.	+8.49%	168B

Other Pharmaceuticals

Pharmanutra S.p.A.

Equities

PHN

IT0005274094

Pharmaceuticals

The importance of iron in pregnancy: benefits for mothers and babies

EPS Revisions